Skip to content

XERIS PHARMACEUTICALS INC

CIK 0001346302

← back to feed
Revenue (TTM)
$28.28M
+1,138.8% YoY Q2 Jul 2021
Net Income (TTM)
−$86.03M
+27.4% YoY Q2 Jul 2021
EPS Diluted (TTM)
—
Q2 Jul 2021
Gross Margin
68.0%
Q2 Jul 2021
Operating Margin
-277.5%
Q2 Jul 2021
Net Margin
-304.2%
Q2 Jul 2021
Free Cash Flow (TTM)
−$81.94M
Q2 Jul 2021
Cash
$63.6M
Q2 Jul 2021
Total Debt
$35M
Q2 Jul 2021
Shares Outstanding
66.5M sh
Q2 Jul 2021

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings